Jennison Associates’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-122,430
Closed -$1.6M 639
2022
Q3
$1.6M Buy
+122,430
New +$1.6M ﹤0.01% 468